AI assistant
Sending…
LOEWS CORP — Director's Dealing 2017
Nov 30, 2017
30284_dirs_2017-11-30_3092dacb-32ec-456c-aed4-0c4e84037e50.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LOEWS CORP (L)
CIK: 0000060086
Period of Report: 2017-11-29
Reporting Person: BERMAN ANN E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-29 | Common Stock | M | 1500 | $40.34 | Acquired | 1500 | Direct |
| 2017-11-29 | Common Stock | M | 1500 | $47.71 | Acquired | 3000 | Direct |
| 2017-11-29 | Common Stock | M | 1500 | $38.38 | Acquired | 4500 | Direct |
| 2017-11-29 | Common Stock | M | 1500 | $27.11 | Acquired | 6000 | Direct |
| 2017-11-29 | Common Stock | D | 4617 | $49.86 | Disposed | 1383 | Direct |
| 2017-11-29 | Common Stock | S | 1383 | $50.30 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-29 | Stock Appreciation Right | $40.34 | M | 1500 | Disposed | 2018-03-31 | Common Stock (1500) | Direct |
| 2017-11-29 | Stock Appreciation Right | $47.71 | M | 1500 | Disposed | 2018-06-30 | Common Stock (1500) | Direct |
| 2017-11-29 | Stock Appreciation Right | $38.38 | M | 1500 | Disposed | 2018-09-30 | Common Stock (1500) | Direct |
| 2017-11-29 | Stock Appreciation Right | $27.11 | M | 1500 | Disposed | 2018-12-31 | Common Stock (1500) | Direct |
Footnotes
F1: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost.
More from LOEWS CORP
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Feb 18
Director's Dealing
2026
Feb 18